비교리스트

 카트 문의
시장보고서
상품코드
1271366

기관내 튜브 시장 규모, 시장 점유율, 용도 분석, 지역 전망, 성장 동향, 주요 기업, 경쟁 전략 및 예측(2023-2031년)

Endotracheal Tubes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 기관내 튜브 시장은 2023년부터 2031년까지 예측 기간 동안 CAGR 6.5%로 확대될 것으로 예상됩니다. 심혈관 질환, 암 및 기타 호흡기 질환과 같은 만성 질환 증가로 인해 기관내 튜브가 필요한 수술 건수가 증가하고 있으며, 2019년 세계보건기구(WHO) 보고서에 따르면 호흡기 질환은 세계 주요 사망 원인으로 연간 약 400만 명의 사망자를 차지합니다. 이에 따라 이 시장은 향후 몇년 동안 유리한 성장세를 보일 것으로 예상됩니다.

수술 건수 증가가 시장 성장을 가속할 것입니다.

기관내 튜브에 대한 수요는 수술 건수 증가로 인해 촉진되고 있으며, 'Global Surgery and Anaesthesia Statistics' 보고서에 따르면 연간 약 31억 3,000만 건의 수술이 이루어지고 있습니다. 기관내 삽관 기술의 발전은 튜브와 관련된 감염 위험을 줄였을 뿐만 아니라 제품의 안전성을 향상시켰습니다. 기관내 튜브나 인공호흡기를 48시간 이상 착용한 환자는 인공호흡기 관련 폐렴(VAP)에 걸릴 확률이 가장 높으며, 이 질환은 증가하는 추세다. 이에 따라 많은 시장 참여자들이 VAP를 줄일 수 있는 항균 및 항응고 코팅이 적용된 제품을 개발하기 위해 노력하고 있습니다. 예를 들어, Medtronic Shiley Evac 기관내 튜브는 VAP를 50.0% 감소시킨 것으로 보고되었습니다. 따라서 VAP 발생률이 높아짐에 따라 코팅된 기관내 튜브에 대한 수요도 증가하여 시장 확대에 박차를 가하고 있습니다. 결과적으로 기관내 튜브의 기술 발전과 많은 만성 질환에 걸리기 쉬운 고령화로 인해 예측 기간 동안 시장 성장 기회가 증가할 것으로 예상됩니다.

팬데믹의 영향에 따른 시장 성장과 기술 혁신 촉진

호흡 곤란은 감염의 명백한 징후이기 때문에 COVID-19의 출현으로 기관내 튜브에 대한 수요가 크게 증가하여 시장 확대의 원동력이되었으며, COVID 환자의 호흡 부전의 경우 미국 기관지 학회는 Open Surgical Tracheostomy(OST) 또는 경피적 확장 기관 절개술을 제안합니다. 확장 기관절개술을 제안하고 있습니다. 이번 팬데믹은 긴급한 제품 승인을 가능하게 했습니다. 미국 생명공학 기업 N8은 캐나다 보건부로부터 기계식 인공호흡을 받고 있는 코로나19 환자를 위한 CeraSheild 기관내 튜브의 긴급 사용 승인을 받았습니다. 이 회사의 특허 제품인 방오 코팅은 치명적인 세균 감염을 예방하기 위한 것입니다. 기관내 삽관 및 인공호흡은 코로나19 환자의 호흡을 지원하여 면역체계가 바이러스와 싸우는 동안 환자가 생존할 수 있도록 돕습니다. 이는 바이러스와 성공적으로 싸울 수 있는 가능성을 높인다. 이러한 시나리오는 시장 확대를 촉진할 것으로 예상됩니다.

기관내 튜브의 기술 발전이 증가함에 따라 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다.

병원 감염을 예방하기 위해 제조업체들은 혁신적인 기관내 튜브 개발에 주력하고 있습니다. 예를 들어, N8 Medical, LLC는 지난 2월 FDA에 CeraShield Endotracheal Tube(ETT)의 첫 인간 대상 임상시험을 위한 IDE(Investigational Device Exemption)를 제출했습니다. 이 임상시험의 목적은 CeraShield 기관내관(ETT)의 안전성과 유효성을 평가하는 것입니다.

시장 성장을 저해하는 병원 내 감염 위험

기계적 인공호흡에 따른 폐렴과 같은 감염을 획득한 병원이 삽관 튜브 시장의 성장을 가속하고 있습니다. 중환자실에서는 시술 합병증 등으로 인해 환자가 사망할 위험이 가장 높은데, 그 중 하나가 병원 내 감염과 같은 이차적 과정으로 인한 중증화입니다.

정기적인 기관내 튜브가 유형별 시장을 독식합니다.

2022년에는 호흡기 질환의 유병률 증가에 따른 수술 증가로 인해 일반 기관내 튜브 부문이 32.5%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다. 또한, VAP 발생률이 증가함에 따라 기관내 튜브에 대한 수요는 향후 증가할 것으로 예상됩니다. 그 결과, 이 분야는 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다. 시장은 제품 유형에 따라 일반 기관내 튜브, 강화 기관내 튜브, 성능 기관내 튜브 및 이중 루멘 기관내 튜브로 분류됩니다.

경로별로는 오로트라케일 부문이 시장을 독식

2022년 시장에서는 기관 절개술 부문이 65%의 가장 큰 매출 점유율을 차지했습니다. 시장은 경로 유형에 따라 기관내 및 비강 기관으로 분류됩니다. 기관 삽관은 적용 범위가 넓고 활용도가 높으며 편안하기 때문에 가장 큰 시장 점유율을 차지했습니다. 기관 삽관은 모든 수술 환자의 기도를 확보하는 데 사용됩니다. 또한 중상을 입은 환자나 다발성 장기 질환을 앓고 있는 중증 환자에게도 사용됩니다.

응급처치 시장은 용도별로 세분화되어 있습니다.

2022년, 응급 치료 부문은 시장의 55%로 가장 큰 매출 점유율을 차지했습니다. 용도별로는 응급처치, 치료, 기타로 세분화됩니다. 이 부문의 가장 큰 점유율은 심정지, 호흡기, 기도폐쇄 및 환기 부족과 같은 응급 상황의 발생률 증가, 교통 사고 사례 증가, 개발도상국의 가처분 소득 증가 등에 기인하는 것으로 보입니다. 그러나 예측 기간 동안 치료 분야는 더 큰 성장을 이룰 것으로 예상됩니다. 예측 기간 동안 이 부문의 성장은 주로 외과 수술 증가, 만성 호흡기 질환의 유병률, 고령화에 의해 주도될 것으로 보입니다.

병원 부문이 최종사용자 시장을 독점

2022년 세계 입원 추세로 인해 병원 부문이 35% 이상의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 시장은 최종 사용자별로 병원, 외래수술센터(ASC), 클리닉 및 기타로 분류됩니다. 또한, 병원 의사와 간호사의 높은 인지도가 이 부문 시장 점유율 확대에 기여하고 있습니다. 클리닉 시장은 예측 기간 동안 가장 큰 성장을 보일 것으로 예상됩니다. 만성 호흡기 질환 증가, 클리닉의 이점에 대한 인식 증가, 공정한 상환 정책이 이 시장 부문의 성장을 가속할 것입니다. 그러나 외래수술센터(ASC)는 북미와 아시아태평양의 센터 확대로 인해 예측 기간 동안 큰 성장을 이룰 것으로 예상됩니다.

북미가 매출 점유율을 독식하고 APAC이 성장 리더로 부상할 것

고도의 의료 시스템과 만성 질환의 유병률 증가로 인해 2022년 기관내 튜브 시장은 북미가 세계 매출의 35% 이상을 차지하며 압도적인 존재감을 드러낼 것으로 예상됩니다. 또한, 이 지역에는 시장 확대에 기여한 중요한 시장 진출기업이 존재하며, Teleflex Incorporated, Medline Industries, Medtronic은 이 지역에서 가장 유명한 기업입니다.

기술 혁신이 시장 점유율 확대의 열쇠를 쥐고 있습니다.

헬스케어 강화를 위해 첨단 헬스케어 기술을 빠르게 도입하는 것은 시장 경쟁력에 영향을 미치는 중요한 요인으로 작용하고 있습니다. 신제품 출시 외에도 주요 기업들은 시장 점유율을 유지하고 제품 포트폴리오를 다양화하기 위해 M&A를 자주 실시하고 있으며, Medtronic Plc, Teleflex Inc, ConvaTec Inc, Smiths Medical, Neurovision Medical Products, Intersurgical Inc, Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc, Bactiguard, N8 Medical LLC 및 기타 주목할만한 업체들은 기관내 튜브 시장의 주요 기업 중 일부입니다.

목차

제1장 서문

  • 보고서의 내용
    • 보고서의 목적
    • 대상 독자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법
    • 단계 Ⅰ - 2차 조사
    • 단계 Ⅱ - 1차 조사
    • 단계 Ⅲ - 전문가 패널 리뷰
    • 전제조건
    • 채택한 접근

제2장 주요 요약

  • 시장 현황 : 세계의 기관내 튜브 시장
  • 세계의 기관내 튜브 제품별 시장, 2022
  • 경로 유형별 세계의 기관내 튜브 시장, 2022
  • 용도별 세계의 기관내 튜브 시장, 2022
  • 최종 용도별 세계의 기관내 튜브 시장, 2022
  • 지역별 세계의 기관내 튜브 시장, 2022
  • 매력적인 투자 제안 : 지역별, 2022

제3장 기관내 튜브 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택하는 전략
  • 주요 산업 전략
  • Tier 분석 : 2022 vs. 2031

제4장 기관내 튜브 시장 : 매크로 분석과 시장 역학

  • 서론
  • 세계의 기관내 튜브 매출, 2021-2031
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 주요 과제
    • 주요 기회
  • 성장 촉진요인과 억제요인의 영향 분석
  • See-Saw 분석

제5장 기관내 튜브 제품별 시장, 2021-2031

  • 시장 개요
  • 성장 및 매출 분석 : 2022 vs. 2031
  • 시장 세분화
    • 일반 기관내 튜브
    • 강화 기관내 튜브
    • 예비 성형 기관내 튜브
    • 더블 루멘 기관내 튜브

제6장 기관내 튜브 경로 유형별 시장, 2021-2031

  • 시장 개요
  • 성장 및 매출 분석 : 2022 vs. 2031
  • 시장 세분화
    • 경구 기관
    • 경비 기관

제7장 기관내 튜브 용도별 시장, 2021-2031

  • 시장 개요
  • 성장 및 매출 분석 : 2022 vs. 2031
  • 시장 세분화
    • 응급치료
    • 치료
    • 기타

제8장 기관내 튜브 최종 용도별 시장, 2021-2031

  • 시장 개요
  • 성장 및 매출 분석 : 2022 vs. 2031
  • 시장 세분화
    • 병원
    • 클리닉
    • 외래수술센터(ASC)
    • 기타

제9장 북미의 기관내 튜브 시장, 2021-2031

  • 시장 개요
  • 기관내 튜브 제품별 시장, 2021-2031
  • 기관내 튜브 경로 유형별 시장, 2021-2031
  • 기관내 튜브 용도별 시장, 2021-2031
  • 기관내 튜브 최종 용도별 시장, 2021-2031
  • 기관내 튜브 지역별 시장, 2021-2031
    • 북미
      • 미국
      • 캐나다
      • 기타 북미

제10장 영국 및 유럽연합의 기관내 튜브 시장, 2021-2031

  • 시장 개요
  • 기관내 튜브 제품별 시장, 2021-2031
  • 기관내 튜브 경로 유형별 시장, 2021-2031
  • 기관내 튜브 용도별 시장, 2021-2031
  • 기관내 튜브 최종 용도별 시장, 2021-2031
  • 기관내 튜브 지역별 시장, 2021-2031
    • 영국 및 유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽

제11장 아시아태평양의 기관내 튜브 시장, 2021-2031

  • 시장 개요
  • 기관내 튜브 제품별 시장, 2021-2031
  • 기관내 튜브 경로 유형별 시장, 2021-2031
  • 기관내 튜브 용도별 시장, 2021-2031
  • 기관내 튜브 최종 용도별 시장, 2021-2031
  • 기관내 튜브 지역별 시장, 2021-2031
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제12장 라틴아메리카의 기관내 튜브 시장, 2021-2031

  • 시장 개요
  • 기관내 튜브 제품별 시장, 2021-2031
  • 기관내 튜브 경로 유형별 시장, 2021-2031
  • 기관내 튜브 용도별 시장, 2021-2031
  • 기관내 튜브 최종 용도별 시장, 2021-2031
  • 기관내 튜브 지역별 시장, 2021-2031
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카

제13장 중동 및 아프리카의 기관내 튜브 시장, 2021-2031

  • 시장 개요
  • 기관내 튜브 제품별 시장, 2021-2031
  • 기관내 튜브 경로 유형별 시장, 2021-2031
  • 기관내 튜브 용도별 시장, 2021-2031
  • 기관내 튜브 최종 용도별 시장, 2021-2031
  • 기관내 튜브 지역별 시장, 2021-2031
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제14장 기업 개요

  • Medtronic Plc
  • Teleflex Inc.
  • ConvaTec Inc.
  • Smiths Medical
  • Neurovision Medical Products
  • Intersurgical Inc.
  • Royax
  • Novo Klinik-Service GmbH
  • Avanos Medical Inc.
  • Bactiguard
  • N8 Medical LLC
  • 기타
LSH 23.06.14

The global endotracheal tube market is projected to expand at a CAGR of 6.5% during the forecast period of 2023 to 2031. Increasing incidences of chronic diseases such as cardiovascular disease, cancer, and other respiratory diseases have led to an increase in the number of surgical procedures requiring endotracheal tubes. According to the 2019 World Health Organization report, respiratory diseases are the leading cause of death worldwide, accounting for approximately 4.0 million deaths annually. Consequently, the market is anticipated to exhibit lucrative growth over the coming years.

Increased Number of Surgical Procedures to Boost the Market Growth

The demand for endotracheal tubes has been fuelled by an increase in the number of surgeries. According to the report Global Surgery and Anaesthesia Statistics, approximately 313,0 million surgical procedures are performed annually. In addition to reducing the risk of infection associated with tubes, technological advances in endotracheal intubation have enhanced product safety. Patients who have been on an endotracheal tube or mechanical ventilator for more than 48 hours are the most likely to develop Ventilator-Associated Pneumonia (VAP), a condition that has been on the rise. Thus, numerous market participants are developing products with antimicrobial and anticoagulant coatings that can reduce VAP. For instance, it has been reported that Medtronic Shiley Evac endotracheal tubes reduce VAP by 50.0%. Consequently, as the incidence of VAP rises, so does the demand for coated endotracheal tubes, fueling the market's expansion. Consequently, technological advancements in endotracheal tubes and an aging population that is increasingly susceptible to numerous chronic diseases will increase the market's growth opportunities during the forecast period.

Pandemic Impact Boosted the Market Growth and Innovations

As breathing difficulty is a clear indication of infection, the emergence of COVID-19 has greatly increased the demand for endotracheal tubes, which has fueled the market expansion. In cases of respiratory failure in COVID patients, the American Association for Bronchology and Interventional Pulmonology suggests Open Surgical Tracheostomy (OST) or percutaneous dilatational tracheostomy. This pandemic made emergency product approvals possible. N8, a U.S.-based biotechnology company, obtained emergency use authorization from Health Canada for its CeraSheild Endotracheal Tubes in COVID-19 patients receiving mechanical ventilation. The anti-fouling coating on the company's patented product is designed to prevent deadly bacterial infections. Endotracheal intubation and ventilation support a COVID-19 patient's breathing so that the patient can survive while the immune system battles the virus. This increases the likelihood of successfully combating the virus. Such scenarios are anticipated to stimulate market expansion

Increasing Product Approvals and Launches Are Anticipated to Drive Market Expansion During the Forecast Period.

Increased launches and approvals of advanced and efficient endotracheal tubes by key players are anticipated to propel the endotracheal tube market over the coming years. In November 2016, Bactiguard introduced the BIP Endotracheal Tube Evac to prevent ventilator-associated pneumonia in patients (VAP). To prevent ventilator-associated pneumonia (VAP) infections, the innovative BIP Endotracheal Tube Evac has subglottic secretion drainage and a Bactiguard coating.

Increasing Technological Advances in Endotracheal Tubes Are Anticipated to Propel Market Growth During the Forecast Period

In order to prevent hospital-acquired infections, manufacturers are emphasizing the creation of innovative endotracheal tubes. For instance, in February, N8 Medical, LLC submitted to the Food and Drug Administration (FDA) the Investigational Device Exemption (IDE) for the first-in-human clinical study of its CeraShield Endotracheal Tube (ETT). The purpose of the clinical trial is to assess the safety and effectiveness of the CeraShield Endotracheal Tube (ETT).

Nonetheless, the increasing prevalence of hospital-acquired infections, such as ventilator-associated pneumonia, is anticipated to restrain the growth of the endotracheal tube market during the forecast period. According to the National Center for Biotechnology Information, the incidence of ventilator-associated pneumonia (VAP) in the United States ranged from 2 to 16 episodes per 1,000 ventilator days in November 2017.

Risk of Nosocomial Infections to Inhibit the Market Growth

Hospitals that have acquired infections such as pneumonia associated with mechanical ventilation are driving the growth of the intubation tube market. In intensive care units, patients are at the highest risk of death due to procedure complications or other causes, one of which is a critical illness caused by secondary processes, such as nosocomial infection.

Pneumonia, which affects 27% of critically ill patients, is the second most common nosocomial infection, after urinary tract infections. Nearly 86% of nosocomial pneumonia is caused by pneumonia associated with mechanical ventilation.

Mortality associated with ventilator-associated pneumonia has been estimated to range between 0% and 50%. When it comes to assessing attributable mortality, different studies have yielded divergent results due to the diversity of the populations examined.

Regular Endotracheal Tubes Dominated the Market by Type

In 2022, the segment of regular endotracheal tubes dominated the market and held the largest revenue share of 32.5% due to the increasing number of surgical procedures as a result of the rising prevalence of respiratory diseases. Also, as the incidence of VAP rises, the demand for endotracheal tubes is anticipated to increase in the future. As a result, the segment is anticipated to exhibit lucrative growth over the forecast period. The market has been divided into regular endotracheal tubes, reinforced endotracheal tubes, performed endotracheal tubes, and double-lumen endotracheal tubes based on the type of product.

However, the reinforced endotracheal tube segment is expected to grow at a faster rate over the forecast period due to its increasing use during surgery and recent technological advancements in endotracheal tubes. In addition, the increasing incidence of road accidents and trauma injuries will contribute to the segment's growth over the forecast period.

Orotracheal Segment Dominated the Market by Route Type

In 2022, the orotracheal segment held the largest revenue share of 65% of the market. The market has been classified as orotracheal and nasotracheal based on route type. Orotracheal has the largest market share due to its broad applicability, increased utilization, and comfort. Orotracheal intubation is utilized to control the airway of any surgical patient. It is also used for patients with severe injuries or multisystem diseases who are critically ill.

Orotracheal incubation is commonly used in emergency situations such as respiratory or cardiac arrest, inadequate oxygenation or ventilation, failure to protect the airway from aspiration, and existing or anticipated airway obstruction. Due to this, the demand for orotracheal tubes has increased over the past few years, and the segment is expected to grow at a healthy rate over the forecast period. Additionally, the aforementioned factors will increase demand for orotracheal intubation over the forecast period. Due to the rising prevalence of respiratory disease, it is anticipated that the nasotracheal segment will experience the highest CAGR of 5.6% during the forecast period.

The Emergency Treatment Market Dominated the Application Segment

In 2022, the emergency treatment segment held the largest revenue share of 55% of the market. The market is further segmented by application into emergency treatment, therapy, and others. The largest share of this segment can be attributed to the rising incidence of emergency conditions such as cardiac arrest and respiratory, airway obstruction and inadequate ventilation, rising cases of road accidents, and growing disposable income in developing nations. Nonetheless, the therapy segment is anticipated to experience greater growth during the forecast period. During the forecast period, the segment's growth will be driven primarily by the increasing volume of surgical procedures, the prevalence of chronic respiratory diseases, and the aging population.

Hospital Segment Dominated the End User Market

In 2022, the hospital's segment held the largest revenue share at over 35% due to the global trend toward hospitalization. The market has been segmented by end-use into hospitals, ambulatory surgical centers, clinics, and others. In addition, high awareness among hospital physicians and nursing staff contributes to the segment's increasing market share. The clinics market segment is anticipated to experience the greatest growth during the forecast period. The increasing prevalence of chronic respiratory diseases, rising awareness of the benefits of clinics, and equitable reimbursement policies will drive the expansion of this market segment. However, ambulatory surgical centers are also anticipated to experience significant growth over the forecast period due to the expansion of centers in North America and Asia-Pacific.

North America to Dominate the Revenue Share and APAC to Emerge as Growth Leader

Due to its advanced healthcare system and rising prevalence of chronic diseases, North America dominated the endotracheal tubes market in 2022, accounting for more than 35% of the global revenue. In addition, the presence of significant market participants in the region contributed to market expansion. Teleflex Incorporated, Medline Industries, and Medtronic are three of the region's most prominent companies.

In 2022, the United States contributed over 30% of the global Intubation Tube Market revenue. The increase in tracheal diseases, such as tracheal stenosis, bronchial tumors, and tracheobronchomalacia, has increased the country's demand for intubation tubes. The National Cancer Institute estimates that there will be 236 740 new cases of lung and bronchial cancer in the United States in 2022, which represents 12.3% of all new cancer cases. This will bring the death toll for this disorder to 130,180, or 21.4% of all cancer-related deaths in the country.

Asia-Pacific is anticipated to experience the market's fastest growth over the forecast period. The increasing geriatric population with respiratory disease, rising prevalence of ventilator-associated pneumonia, and rising number of surgeries due to chronic cardiovascular disease are expected to increase regional demand for endotracheal tubes.

Technology Innovation to Remain as the Key to Enhance Market Shares

The rapid adoption of advanced healthcare technology for enhanced healthcare is a crucial factor influencing the market's competitiveness. In addition to new product launches, major players frequently engage in mergers and acquisitions in order to retain market share and diversify their product portfolios. Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, N8 Medical LLC and Other Notable Players are some of the key players in the endotracheal tube market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Endotracheal Tubes market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Endotracheal Tubes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Regular Endotracheal Tube
  • Reinforced Endotracheal Tube
  • Preformed Endotracheal Tube
  • Double lumen Endotracheal Tube
  • Route Type
  • Orotracheal
  • Nasotracheal

Application

  • Emergency Treatment
  • Therapy
  • Others

End-use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Endotracheal Tubes market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Endotracheal Tubes market?
  • Which is the largest regional market for Endotracheal Tubes market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Endotracheal Tubes market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Endotracheal Tubes market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Endotracheal Tubes Market
  • 2.2. Global Endotracheal Tubes Market, By Product, 2022 (US$ Million)
  • 2.3. Global Endotracheal Tubes Market, By Route Type, 2022 (US$ Million)
  • 2.4. Global Endotracheal Tubes Market, By Application, 2022 (US$ Million)
  • 2.5. Global Endotracheal Tubes Market, By End-use, 2022 (US$ Million)
  • 2.6. Global Endotracheal Tubes Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Endotracheal Tubes Market: Competitive Analysis

  • 3.1. Market Positioning of Key Endotracheal Tubes Market Vendors
  • 3.2. Strategies Adopted by Endotracheal Tubes Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Endotracheal Tubes Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Endotracheal Tubes Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Regular Endotracheal Tube
    • 5.3.2. Reinforced Endotracheal Tube
    • 5.3.3. Preformed Endotracheal Tube
    • 5.3.4. Double lumen Endotracheal Tube

6. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Orotracheal
    • 6.3.2. Nasotracheal

7. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Emergency Treatment
    • 7.3.2. Therapy
    • 7.3.3. Others

8. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Others

9. North America Endotracheal Tubes Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
  • 9.3. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
  • 9.4. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
  • 9.5. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
  • 9.6.Endotracheal Tubes Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.1.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 9.6.1.1.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.2.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 9.6.1.2.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.3.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 9.6.1.3.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

10. UK and European Union Endotracheal Tubes Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
  • 10.3. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
  • 10.4. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
  • 10.5. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
  • 10.6.Endotracheal Tubes Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.1.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.1.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.2.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.2.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.3.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.3.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.4.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.4.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.5.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.5.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.6.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 10.6.1.6.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

11. Asia Pacific Endotracheal Tubes Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
  • 11.3. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
  • 11.4. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
  • 11.5. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
  • 11.6.Endotracheal Tubes Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.1.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.1.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.2.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.2.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.3.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.3.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.4.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.4.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.5.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.5.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.6.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 11.6.1.6.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

12. Latin America Endotracheal Tubes Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
  • 12.3. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
  • 12.4. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
  • 12.5. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
  • 12.6.Endotracheal Tubes Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.1.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 12.6.1.1.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.2.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 12.6.1.2.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.3.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 12.6.1.3.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

13. Middle East and Africa Endotracheal Tubes Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
  • 13.3. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
  • 13.4. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
  • 13.5. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
  • 13.6.Endotracheal Tubes Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.1.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 13.6.1.1.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.2.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 13.6.1.2.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Endotracheal Tubes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.3.1. Endotracheal Tubes Market: By Route Type, 2021-2031, USD (Million)
        • 13.6.1.3.1. Endotracheal Tubes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. Endotracheal Tubes Market: By End-use, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Medtronic Plc
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Teleflex Inc.
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. ConvaTec Inc.
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Smiths Medical
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Neurovision Medical Products
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Intersurgical Inc.
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Royax
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Novo Klinik-Service GmbH
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Avanos Medical, Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Bactiguard
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. N8 Medical LLC
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Other Notable Players
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제